Hamartoma risk factors

Hamartoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hamartoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hamartoma risk factors On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hamartoma risk factors All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hamartoma risk factors
CDC on Hamartoma risk factors
Hamartoma risk factors in the news
Blogs on Hamartoma risk factors
Directions to Hospitals Treating Hamartoma
Risk calculators and risk factors for Hamartoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

The most potent risk factor in the development of hamartomas is familial hamartomatous syndromes.

Risk factors

• The most potent risk factor in the development of hamartomas is familial hamartomatous syndromes.
• Risk factors associated with hamartomatous formation, include:

• Juvenile polyposis syndrome
• Peutz-Jeghers syndrome
• Hereditary mixed polyposis syndrome
• PTEN hamartoma tumour syndrome
• Tuberous sclerosis
• Cowden’s syndrome
• Bannayan-Riley-Ruvalcaba syndrome